Menlo Ventures and A16z Back AI Startup Phylo in Undisclosed Funding Round

Why It Matters

The funding accelerates commercialization of AI tools that could dramatically shorten research cycles, reshaping biotech and materials science pipelines. Investors see Phylo as a catalyst for next‑generation scientific productivity.

Key Takeaways

• a16z and Menlo lead $15M seed round
• Founders are recent Stanford PhDs in AI research
• Phylo targets AI-driven scientific discovery platforms
• Jure Leskovec joins as advisor and co‑founder
• Platform aims to automate hypothesis generation

Pulse Analysis

Phylo’s seed financing underscores a growing appetite among top‑tier venture firms for AI‑centric scientific tools. Andreessen Horowitz and Menlo Ventures, both known for backing transformative technology, committed $15 million, providing the startup with not only capital but strategic guidance. The founding team—Le Cong and Yuanhao Qu—recently defended their PhDs at Stanford, bringing cutting‑edge expertise in machine learning for scientific inference, while renowned computer‑science professor Jure Leskovec adds credibility and industry connections.

At its core, Phylo is developing an “AI scientist” platform that leverages large‑scale language models and graph neural networks to propose testable hypotheses, design experiments, and interpret results across domains such as drug discovery, materials engineering, and climate research. By automating the early stages of the scientific method, the company promises to cut months, if not years, from development timelines, addressing a critical bottleneck where human expertise is scarce and data volumes are exploding. Early pilots with university labs and biotech firms suggest the technology can surface novel insights that traditional computational pipelines miss.

The broader market is rapidly coalescing around AI‑augmented research, with competitors ranging from established cloud providers to niche biotech AI startups. Phylo’s differentiator lies in its end‑to‑end workflow and deep integration of hypothesis generation with experimental design, positioning it to become a foundational layer for next‑generation R&D. If successful, the startup could trigger a wave of productivity gains, prompting further investment and potentially reshaping how scientific discovery is funded and executed worldwide.

Deal Summary

Menlo Ventures and Andreessen Horowitz (a16z) have invested in Phylo, an AI scientist startup founded by Stanford researchers Le Cong, Yuanhao Qu, Kexin Huang, and Jure Leskovec. The funding round was announced on February 3, 2026, with undisclosed terms.